Year: 2022

– Dr. Craig Hopkinson, currently EVP of Research & Development and Chief Medical Officer at Alkermes, brings strong global orphan drug development expertise – Dr. Paul Streck, former Chief Medical Officer at Arena Pharmaceuticals, brings significant global drug development and commercialization expertise – Two appointments strengthen Company’s ability to scale up global drug development and grow the portfolio BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators to treat pediatric and adult liver diseases, today announced the appointments of two scientific leaders, Drs. Paul Streck and Craig Hopkinson, to the Enterprise Leadership Team and Board of Directors, respectively. These appointments coincide with an important time for Albireo...

BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the abstract publication and poster presentation at the American Society of Health-System Pharmacists (ASHP) conference in Las Vegas, Nevada, December 4 – 8. The abstract being presented highlights research that was conducted by integrating multiple clinical and claims databases that track a large cohort of kidney failure patients on hemodialysis (HD) with central venous catheters (CVCs). The conclusions from this retrospective study further underscore the significant mortality risk and long-term complications associated with catheter-related bloodstream infections...

Edible Garden Products to be Available in 29 Gristedes and D’Agostino retail locations, situated in densely populated, high-traffic Urban Areas, in Manhattan, Brooklyn and Westchester Counties BELVIDERE, NJ, Dec. 06, 2022 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced an expansion of its distribution with Gristedes and D’Agostino supermarkets to sell Edible Garden products in 29 of their combined locations in Manhattan, Brooklyn and Westchester. In addition to an expansion of the distribution network, Edible Garden plans to collaborate with Gristedes and D’Agostino on the display and strategic placement of Edible Garden’s products within their...

Studies are Supported and Funded Through Cooperative Agreement Grants from the National Cancer Institute GFH009 to be Evaluated Against Pediatric Solid Tumors and Leukemia Models at Eight Participating Research Institutions NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that SELLAS’ highly selective CDK9 inhibitor, GFH009, will be evaluated in pediatric solid tumors and leukemia models through the National Cancer Institute (NCI) Pediatric Preclinical in Vivo Testing (PIVOT) Program. GFH009 testing through the program involves a two-phase research plan for pharmacokinetics (PK) and efficacy in pediatric tumors....

CINCINNATI, Dec. 06, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the Company will host an online Key Opinion Leader (“KOL”) event on Wednesday, December 7, 2022 from 12 p.m. – 2 p.m. EST. To kick off the event, Joseph Hernandez, Chairman and Chief Executive Officer of Blue Water Vaccines, will provide a brief Company overview and deliver a welcome message to participants. Following this introduction, Ali Fattom, Ph.D., will give an introduction to vaccines, the importance and benefits of vaccines that elicit mucosal immunity, the current pneumococcal vaccine landscape, and the need for an efficacious, intranasal pneumococcal vaccine. Then, Jason...

MIAMI, Dec. 06, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Fortress will participate in one-on-one meetings at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference, which is being held on Thursday, December 8, 2022 in Miami, FL. About Fortress Biotech Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. The company has eight marketed prescription pharmaceutical products and over 30 programs in development...

TAC-450 Inertial Measurement Units (IMUs) feature a compact design, robust performance, and survivability to meet the needs of commercial and military platforms ALHAMBRA, CA, Dec. 06, 2022 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense, communications, and sensing markets, announced today the introduction of the TAC-450 line of Inertial Measurement Units (IMUs), which includes three high-performance IMUs with tactical-grade photonic Fiber Optic Gyros (FOGs), and features EMCORE′s patented Photonic Integrated Chip (PIC) technology. The EMCORE TAC-450 line of IMUs are offered in a compact housing resulting in a smaller, lighter package that expands the types of potential autonomous applications that can use EMCORE’s new IMU technology....

CHARLOTTE, N.C., Dec. 06, 2022 (GLOBE NEWSWIRE) — STRONG/MDI Screen Systems, Inc. (“STRONG/MDI”) a wholly-owned subsidiary of Ballantyne Strong, Inc. (“Ballantyne Strong”) (NYSE American: BTN) and a leader in manufacturing of state-of-the-art Cinema Screens announced it has signed an exclusive three-year cinema screen supply agreement with Marcus Theatres. Ray Boegner, President of Strong Entertainment, commented, “We are pleased to continue our long-running partnership with Marcus Theatres, helping them provide a premium cinema experience to their customers in their theatres across the United States. We continue to partner with leading cinemas to provide them with the best in projection screen quality and technology, and we look forward to expanding our partnership network as more and more cinemas throughout the U.S. and globally...

PUBLICIS GROUPE’S ‘USEFUL WISHES’ With the help of a special guest, Maurice Lévy and Arthur Sadoun put the spotlight on HPV-related cancer. Paris – December 6, 2022 – 2022 has been a stellar year for Publicis on every front. But rather than celebrate those achievements, the group is leveraging the impact of its annual Wishes film to drive awareness around the Human Papilloma Virus.   Despite the fact that 80% of all adults will contract HPV at some point in their lives, for far too long cancers related to this virus have been hidden, shushed, stigmatized. They have therefore become a pervasive silent killer.  This is a particularly personal theme for Publicis Groupe CEO Arthur Sadoun as he was diagnosed and treated for HPV-related cancer earlier this year.  HPV is linked to a significant rise in cancers in both men and women, despite...